Our Phd. Pan Sun published her work on Alzheimer's & Dementia.

More information please refer to https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.14176

Abstract

INTRODUCTION

The spatial and temporal patterns of cortical mean diffusivity (cMD), as well as its association with Alzheimer's disease (AD) and suspected non-Alzheimer's pathophysiology (SNAP), are not yet fully understood.

METHODS

We compared baseline (n = 617) and longitudinal changes (n = 421) of cMD, cortical thickness, and gray matter volume and their relations to vascular risk factors, amyloid beta (Aβ), and tau positron emission tomography (PET), and longitudinal cognitive decline in Aβ PET negative and positive older adults.

RESULTS

cMD increases were more sensitive to detecting brain structural alterations than cortical thinning and gray matter atrophy. Tau-related cMD increases partially mediated Aβ-related cognitive decline in AD, whereas vascular disease-related increased cMD levels substantially mediated age-related cognitive decline in SNAP.

DISSCUSSION

These findings revealed the dynamic changes of microstructural and macrostructural indicators and their associations with AD and SNAP, providing novel insights into understanding upstream and downstream events of cMD in neurodegenerative disease.

HIGHLIGHTS

• Cortical mean diffusivity (cMD) was more sensitive to detecting structural changes than macrostructural factors.

Tau-related cMD increases partially mediated amyloid beta–related cognitive decline in Alzheimer's disease (AD).
White matter hyperintensity–related higher cMD mainly explained the age-related cognitive decline in suspected non-Alzheimer's pathophysiology (SNAP).
cMD may assist in tracking earlier neurodegenerative signs in AD and SNAP.